Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
American Journal of Therapeutics|November 5, 2013
Side effects and toxicities of targeted therapies in stage IV melanomaPaolo A Ascierto, Lars Bastholt, Peter Hersey, et al.
Trends in Immunology|March 12, 2019
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to ImmunotherapyAbdullah Al Emran, Aniruddha Chatterjee, Euan J Rodger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatinKelly A Avery-Kiejda, Xu Dong Zhang, Luke J Adams, et al.
Cancers|August 1, 2020
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two CohortsAbdullah Al Emran, Jérémie Nsengimana, Gaya Punnia-Moorthy, et al.
Anti-Cancer Drugs|January 8, 2008
Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cellsLin Jie Zhang, Yuan Zhang Hao, Chun Song Hu, et al.
Pageof 16